1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism
about
Hormones and the immune response.Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritisCommitment and differentiation of stem cells to the osteoclast lineage.Vitamin D and the immune system: new perspectives on an old theme.Osteoclasts and giant cells: macrophage-macrophage fusion mechanism.Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.Regulation of metallothionein gene expression by 1 alpha,25-dihydroxyvitamin D3 in cultured cells and in mice1,25-Dihydroxyvitamin D3 maintains adherence of human monocytes and protects them from thermal injuryVitamin D metabolism and innate immunityInterleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activityInterleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells.Macrophage multinucleation is accompanied by the expression of new soluble and membrane antigens in miceAn assessment of the ability of human bone marrow cultures to generate osteoclasts.Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption.1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrowVitamin D and the Immune System from the Nephrologist's Viewpoint.Activation and fusion induced by 1 alpha,25-dihydroxyvitamin D3 and their relation in alveolar macrophages.Vitamin D3: a helpful immuno-modulator.Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation.The Active Metabolite of Vitamin D3 as a Potential Immunomodulator.Transient expression of M-CSF is important for osteoclast-like cell differentiation in a monocytic leukemia cell line.Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases.Inhibition by prostaglandin E1 and E2 of 1,25-dihydroxyvitamin D3 synthesis by synovial fluid macrophages from arthritic jointsInterleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin-6, but not by 1 alpha,25-dihydroxyvitamin D3.Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.The vitamin D analogue paricalcitol attenuates hepatic ischemia/reperfusion injury through down-regulation of Toll-like receptor 4 signaling in rats.Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids.Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications
P2860
Q33561339-B6A6C842-852F-464F-A23F-CCE14119E15FQ33567459-4B33B947-6B64-464D-9DE3-9072C9655B22Q33678395-481CFA5F-C337-421A-982E-EC306754B1FBQ33888744-D1F9746C-0CF0-466E-AF78-E27D3BB0A80BQ34135727-41913B75-AFD5-4CEA-8C28-66FA5A0AF482Q34273000-AF393E5D-C346-4C16-BA99-975BFBCAC55BQ34375661-A5ACB531-297D-47FE-9F9B-EFED0E3A6D90Q34575123-0818BCF6-5147-4E8D-911C-9CA2F90B976DQ35435053-60D51F50-2D2C-467C-A076-14FB88E1EB23Q35782114-9CD9B092-1E99-4254-A4A3-9130559AD619Q35795586-3A87A9CF-4A79-438C-B864-260A67A53430Q35816768-3A1A94BA-609C-4AFB-A80E-A99E93D0EB18Q36029382-8735062B-388A-47EC-96BB-345E18F6E362Q37394770-711192A2-3E82-41B3-8155-E87293E03532Q37557858-9C8BF2ED-4D59-47DD-BD3D-C2B1990CA2F2Q37576846-90D0E898-052E-4E91-AF30-EE8456FB974CQ37577300-A114C838-9638-4D6A-B412-07638987E6F1Q37927252-C29706AB-D3B8-4BDF-9F68-0920D3EFD41DQ38108294-F2994C66-9013-4978-A140-9CA1BEF1A4A6Q38672342-5A36FDD9-7F7B-46C1-98CA-637B08A08646Q41142087-655804D5-60AB-4A4D-8B88-5C78D21EACAEQ41211411-B7F5969C-7926-4690-8FE9-8250C985D116Q41290928-D1B752F4-7F35-40D7-B530-93959242F7BCQ41660478-B0BA3DFE-3AD7-4C87-A422-931CBAE33B4AQ41790378-5A348FD0-0B01-48BF-85E4-2F07D4F9910BQ41956279-5F6E7DD9-B171-4323-A5EE-702EC8AE60BCQ44478302-DDFA263A-A131-445A-83A7-0193F84B54EDQ58757535-4A3EDC1F-AEE0-42E1-B1D4-84D54AE528DB
P2860
1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
1 alpha,25-dihydroxyvitamin D3 ...... ll-mediated indirect mechanism
@en
1 alpha,25-dihydroxyvitamin D3 ...... l-mediated indirect mechanism.
@nl
type
label
1 alpha,25-dihydroxyvitamin D3 ...... ll-mediated indirect mechanism
@en
1 alpha,25-dihydroxyvitamin D3 ...... l-mediated indirect mechanism.
@nl
prefLabel
1 alpha,25-dihydroxyvitamin D3 ...... ll-mediated indirect mechanism
@en
1 alpha,25-dihydroxyvitamin D3 ...... l-mediated indirect mechanism.
@nl
P2093
P2860
P356
P1476
1 alpha,25-dihydroxyvitamin D3 ...... ll-mediated indirect mechanism
@en
P2093
Kuribayashi T
P2860
P304
P356
10.1073/PNAS.80.18.5583
P407
P577
1983-09-01T00:00:00Z